Systemic effects of chronic obstructive pulmonary disease
- PMID: 12608452
- DOI: 10.1183/09031936.03.00405703
Systemic effects of chronic obstructive pulmonary disease
Abstract
Chronic obstructive pulmonary disease (COPD) is characterised by an inappropriate/excessive inflammatory response of the lungs to respiratory pollutants, mainly tobacco smoking. Recently, besides the typical pulmonary pathology of COPD (i.e. chronic bronchitis and emphysema), several effects occurring outside the lungs have been described, the so-called systemic effects of COPD. These effects are clinically relevant because they modify and can help in the classification and management of the disease. The present review discusses the following systemic effects of chronic obstructive pulmonary disease: 1) systemic inflammation; 2) nutritional abnormalities and weight loss; 3) skeletal muscle dysfunction; and 4) other potential systemic effects. For each of these, the potential mechanisms and clinical implications are discussed and areas requiring further research are highlighted.
Similar articles
-
Systemic effects of chronic obstructive pulmonary disease.Proc Am Thorac Soc. 2005;2(4):367-70; discussion 371-2. doi: 10.1513/pats.200504-026SR. Proc Am Thorac Soc. 2005. PMID: 16267364 Review.
-
[Peripheral muscle dysfunction in chronic obstructive pulmonary disease].Pneumologia. 2012 Jul-Sep;61(3):178-82. Pneumologia. 2012. PMID: 23173381 Review. Romanian.
-
Systemic inflammation and skeletal muscle dysfunction in chronic obstructive pulmonary disease: state of the art and novel insights in regulation of muscle plasticity.Clin Chest Med. 2007 Sep;28(3):537-52, vi. doi: 10.1016/j.ccm.2007.06.003. Clin Chest Med. 2007. PMID: 17720042 Review.
-
Systemic manifestations in chronic obstructive pulmonary disease.J Bras Pneumol. 2006 Mar-Apr;32(2):161-71. doi: 10.1590/s1806-37132006000200012. J Bras Pneumol. 2006. PMID: 17273586 Review. English, Portuguese.
-
Skeletal muscle response to inflammation--lessons for chronic obstructive pulmonary disease.Crit Care Med. 2009 Oct;37(10 Suppl):S372-83. doi: 10.1097/CCM.0b013e3181b6ea1d. Crit Care Med. 2009. PMID: 20046123 Review.
Cited by
-
Genome-wide mRNA expression profiling in vastus lateralis of COPD patients with low and normal fat free mass index and healthy controls.Respir Res. 2015 Jan 8;16(1):1. doi: 10.1186/s12931-014-0139-5. Respir Res. 2015. PMID: 25567521 Free PMC article.
-
Prevalence of chronic kidney diseases in patients with chronic obstructive pulmonary disease: assessment based on glomerular filtration rate estimated from creatinine and cystatin C levels.Int J Chron Obstruct Pulmon Dis. 2015 Jul 6;10:1283-9. doi: 10.2147/COPD.S80673. eCollection 2015. Int J Chron Obstruct Pulmon Dis. 2015. PMID: 26185434 Free PMC article.
-
COPD exacerbations.5: management.Thorax. 2006 Jun;61(6):535-44. doi: 10.1136/thx.2005.041863. Thorax. 2006. PMID: 16738044 Free PMC article. Review.
-
Chronic obstructive pulmonary disease severity and cardiovascular outcomes.Eur J Epidemiol. 2006;21(11):803-13. doi: 10.1007/s10654-006-9066-1. Epub 2006 Nov 15. Eur J Epidemiol. 2006. PMID: 17106760
-
The influence of radiographic phenotype and smoking status on peripheral blood biomarker patterns in chronic obstructive pulmonary disease.PLoS One. 2009 Aug 31;4(8):e6865. doi: 10.1371/journal.pone.0006865. PLoS One. 2009. PMID: 19718453 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical